India medical device healthcare
description
Transcript of India medical device healthcare
India Healthcare and Medical Device industry Analysis
Divya Kumar, Neel Mehta, Kavita Tangirala, Jared MckeeHSM502WP Carey MBA –Class of 2014Tempe Campus
Introduction
Republic of India: Facts and Figures
• Location: South Asian country. • 1.2 billion population, 2nd most populous country• 3rd largest economy in Asia and expected to be 3rd largest in the
world by 2050. • Steady GDP growth rate of 8.5% in last 5 years.
Demographics
• 28 states and 7 union territory • 30 official languages + English is widely spoken • World’s largest democracy • Currency is rupees 1 USD = 54.47 INR (www.xe.com @ 12/7/12)
Foreign Direct Investment
• 1991 brought the economic reforms• 3rd Most favorite nation for Foreign Direct Investment (FDI)• $58 Bilateral Indo-US trade (2011)
Healthcare/Medical Technology Market
• $80 billion Healthcare market (KPMG, 2012)
• Expect to reach $280 billion in 2020
• Steady growth of approx. 15%
• $11 billion Pharma market• Expect to reach $74 billion in
2020 (Ernst & Young)
• $5 billon Medical Device market
• Expect to reach CAGR of 15% (KPMG)
Why India?• 2.3% medical device excise Tax in US from 2013• India increases its government share of healthcare expenditure to 2.5%
by 2017 (12th 5 year plan)
http://www.emergogroup.com/files/2012-medical-device-industry-survey.pdf
SWOT AnalysisStrength Weakness
• Hugh market opportunity• English speaking population • World’s largest democracy, stable
democratic govt.• Low cost manufacturing• currency restrictions and reduce tariffs• SEZ (Special Economic Zones)• Tax break holiday • Second largest pool of scientist and
engineer• IFRS Based Accounting practice • Medical tourism
• Slow Reforms Process• The Long List Syndrome• The No Follow –through Syndrome • Lack of infrastructure • Political corruption • Trade barriers • Poor productivity record, FDI, Economic
reforms• Delay in dispute resolution
Opportunity Threats• Rapidly growing market • Small Distributorship Advantage• Middle class disposable income • Change in lifestyle of urban Indians• 1 billion+ market • Foreign Direct Investment Entry
• Fraud and Reliability Checks • Corruption and bribery• Poor copyright law• Foreign relations • Piracy • Social blunders • Macroeconomic concerns (inflation, etc.)
CGMS
• Continuous Glucose Monitoring System
New Class III deviceEffective management of blood glucose levelsComponents: Sensor, transmitter & a wireless
monitorAlerts the patient Downloadable data
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) http://diabetes.niddk.nih.gov/dm/pubs/glucosemonitor/index.aspx
• IndiaPatient base of 63 millionCauses for prevalence:
• Insulin resistance• Abdominal adiposity• Low adiponectin • Higher C-reactive protein• Diet and lifestyle
• Major impediments: Cost and affordability
International Diabetes Federation http://www.idf.org/sites/default/files/IDF_SEA_5E_Update_FactSheet.pdf
Mohan, V., Sandeep, S., Deepa, R., Shah, B., & Varghese, C. (2007). Epidemiology of type 2 diabetes: Indian scenario. The Indian journal of medical research, 125(3), 217-30.
Indian Human Development Surveyhttp://ihds.umd.edu/incomeRU.html
CGMS
Recommendation
• Invest in Indian Market– Medical Device Market growth rate of 15%– “We can expect 12%–16% annual growth over the next 10 to 15 years. All the risk factors
put together are just irritants, which at most can bring growth to 8%–9%. This is still significantly higher than the 2%–3% growth that developed, Western markets are currently experiencing.”
Annaswamy Vaidheesh - Johnson & Johnson
– Emergent Middle Class• Additional 580 million customers
– Growth of Insurance Market
Recommendation Investment Strategy
• Short-Term Strategy – Develop local distribution to distribute Tier 1 products
• Minimize fixed investment • Maintain flexibility • Utilize local sales force
• Long-Term Strategy – Invest in Manufacturing facilities
• Initially produce Tier 2-3 products• 100% Foreign Direct Investment• Utilize Indian facility to supply Asian markets• As markets mature manufacture Tier 1 products